PHARMA MAR, S.A. «12345...» Page 1 out of 26 31/03/2025 17:39 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 24 March and 28 March 2025. Register number: 33801 27/03/2025 12:42 PHARMA MAR, S.A. On business and financial situation Sylentis, a subsidiary of Pharma Mar, will receive €21.1 million from the NextGenerationEU fund for research into rare diseases and the construction of a manufacturing plant. Register number: 33716 26/03/2025 08:31 PHARMA MAR, S.A. On business and financial situation The Company announces proposed dividend distribution. Register number: 33651 24/03/2025 17:38 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 17 March and 21 March 2025. Register number: 33622 17/03/2025 17:39 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 10 March and 14 March 2025. Register number: 33512 10/03/2025 17:39 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 3 March and 7 March 2025. Register number: 33413 28/02/2025 09:46 PHARMA MAR, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2024 Register number: 33153 28/02/2025 09:44 PHARMA MAR, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024 Register number: 33152 28/02/2025 08:45 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The Company informs that it will carry out a program to buy-back treasury shares Register number: 33145 28/02/2025 08:39 PHARMA MAR, S.A. On business and financial situation The Company announces today's conference call with analysts and investors and submits a presentation on the results for the financial year 2024. Register number: 33142 Page 1 out of 26 «12345...»
